Study #2018-0506
A Phase III, Randomized, Double-Blinded, Placebo-Controlled, Multi-Centre Study Evaluating The Safety, Tolerability And Efficacy Of Combination Treatment Of Bl-8040 And G-CSF As Compared To Placebo And G-CSF For The Mobilization Of Hematopoietic Stem Cell
MD Anderson Study Status
Not Accepting
Treatment Agent
BL-8040 1.25 mg/kg + G-CSF, Placebo +G-CSF
Description
A total of 122 subjects were randomized into the study and investigated in the double-blind placebo-controlled setting to assess the efficacy and safety of G-CSF + BL-8040 as compared to G-CSF + placebo.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Multiple Myeloma
Study phase:
Phase III
Physician name:
Muzaffar Qazilbash
Department:
Stem Cell Transplantation
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.